Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rowley

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Epilepsy Research|April 5, 2011
Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult miceA C Lehre, N M Rowley, Y Zhou, et al.
Journal of Medicinal Chemistry|December 24, 1997
Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonistsM Rowley, J J Kulagowski, A P Watt, et al.
Breast Cancer Research : BCR|August 19, 2015
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controlsElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Plos Genetics|October 3, 2012
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility allelesElla R Thompson, Maria A Doyle, Georgina L Ryland, et al.
Journal of the National Cancer Institute|April 6, 2019
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast CancerNa Li, Simone McInerny, Magnus Zethoven, et al.
NPJ Breast Cancer|August 18, 2020
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic densityDane Cheasley, Lisa Devereux, Siobhan Hughes, et al.
Oncotarget|October 28, 2015
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genesSally M Hunter, Michael S Anglesio, Georgina L Ryland, et al.
NPJ Breast Cancer|March 21, 2020
The genetic architecture of breast papillary lesions as a predictor of progression to carcinomaTanjina Kader, Kenneth Elder, Magnus Zethoven, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasisSukanya Chakraborty, Aaqib M Bhat, Insha Mushtaq, et al.
Nature Genetics|September 19, 2018
Mutations in RECQL are not associated with breast cancer risk in an Australian populationNa Li, Simone M Rowley, David L Goode, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Epilepsy Research|April 5, 2011
Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult miceA C Lehre, N M Rowley, Y Zhou, et al.
Journal of Medicinal Chemistry|December 24, 1997
Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonistsM Rowley, J J Kulagowski, A P Watt, et al.
Breast Cancer Research : BCR|August 19, 2015
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controlsElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Plos Genetics|October 3, 2012
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility allelesElla R Thompson, Maria A Doyle, Georgina L Ryland, et al.
Journal of the National Cancer Institute|April 6, 2019
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast CancerNa Li, Simone McInerny, Magnus Zethoven, et al.
NPJ Breast Cancer|August 18, 2020
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic densityDane Cheasley, Lisa Devereux, Siobhan Hughes, et al.
Oncotarget|October 28, 2015
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genesSally M Hunter, Michael S Anglesio, Georgina L Ryland, et al.
NPJ Breast Cancer|March 21, 2020
The genetic architecture of breast papillary lesions as a predictor of progression to carcinomaTanjina Kader, Kenneth Elder, Magnus Zethoven, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasisSukanya Chakraborty, Aaqib M Bhat, Insha Mushtaq, et al.
Nature Genetics|September 19, 2018
Mutations in RECQL are not associated with breast cancer risk in an Australian populationNa Li, Simone M Rowley, David L Goode, et al.
Pageof 21